Can Unisom (doxylamine) be taken with flecainide?
Yes, Unisom (doxylamine) can generally be taken with flecainide, as there are no documented direct drug interactions between these medications in the FDA labeling or major guidelines.
Key Evidence
The FDA drug label for flecainide 1 provides comprehensive information about drug interactions and does not list antihistamines, including doxylamine, as contraindicated or requiring special precautions. The label specifically addresses interactions with:
- Digoxin (13-19% increase in levels)
- Beta-blockers like propranolol (20% increase in flecainide levels, 30% increase in propranolol levels)
- Amiodarone (can double flecainide levels)
- CYP2D6 inhibitors like quinidine
- Cimetidine (30% increase in flecainide levels)
Notably absent from this list are antihistamines or sedative-hypnotics like doxylamine.
Clinical Considerations
What to Monitor
While no direct interaction exists, consider these practical points:
- Sedation: Doxylamine causes drowsiness. If the patient is also on beta-blockers (commonly combined with flecainide per guidelines 2, 3), additive sedation may occur
- QT interval: Neither doxylamine nor flecainide significantly prolongs QT interval in typical doses, but baseline ECG monitoring is already recommended for flecainide therapy 2
- Anticholinergic effects: Doxylamine has anticholinergic properties that could theoretically affect cardiac conduction, though this is not clinically significant at therapeutic doses
Flecainide Context from Guidelines
Current guidelines 2, 4 recommend flecainide for:
- Paroxysmal atrial fibrillation in patients without structural heart disease
- Always combined with AV nodal blocking agents (beta-blockers or calcium channel blockers) to prevent rapid ventricular response
The 2020 Canadian guidelines 2 emphasize that flecainide should be avoided in patients with coronary artery disease, heart failure (LVEF <40%), or significant conduction disease—but make no mention of avoiding common over-the-counter medications like antihistamines.
Common Pitfalls to Avoid
Don't confuse with other drug classes: The concern is NOT about doxylamine, but rather about combining flecainide with other antiarrhythmics (disopyramide, verapamil) which the FDA label 1 specifically cautions against due to additive negative inotropic effects
Don't overlook the real contraindications: Focus monitoring on the well-documented interactions (amiodarone, CYP2D6 inhibitors, cimetidine) rather than theoretical concerns about antihistamines
Ensure proper flecainide use: Verify the patient is on appropriate AV nodal blockade (beta-blocker or calcium channel blocker) as recommended by all major guidelines 2, 3, 4
Bottom Line
Proceed with concurrent use of doxylamine and flecainide. Counsel the patient about expected drowsiness from doxylamine, especially if they're also taking beta-blockers. No dose adjustment of flecainide is needed, and no additional cardiac monitoring beyond standard flecainide management is required.